fingolimod hydrochloride has been researched along with Colorectal Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, DJ; Lee, YM; Oh, YS; Park, EY; Shamshiddinova, M; Shrestha, J | 1 |
| Aguilera, O; Borrero, A; Caramés, C; Cristóbal, I; García-Foncillas, J; Madoz-Gúrpide, J; Manso, R; Martínez-Useros, J; Rincón, R; Rodriguez, M; Rojo, F; Senin, C; Zazo, S | 1 |
| Fei, Q; Hu, J; Li, J; Sun, Y; Sun, YM; Wang, SW; Zhang, C; Zhang, DS; Zhu, CY | 1 |
| Bianco, R; Carlomagno, C; D'Amato, C; D'Amato, V; Damiano, V; De Placido, S; De Stefano, A; Del Vecchio, S; Formisano, L; Greco, A; Malapelle, U; Marciano, R; Marfè, G; Nappi, L; Rosa, R; Troncone, G; Veneziani, BM; Zannetti, A | 1 |
4 other study(ies) available for fingolimod hydrochloride and Colorectal Neoplasms
| Article | Year |
|---|---|
SK1 Inhibitor RB005 Induces Apoptosis in Colorectal Cancer Cells through SK1 Inhibition Dependent and Independent Pathway.
Topics: Apoptosis; Ceramides; Colonic Neoplasms; Colorectal Neoplasms; Fingolimod Hydrochloride; Humans; RNA, Small Interfering | 2022 |
PP2A inhibition is a common event in colorectal cancer and its restoration using FTY720 shows promising therapeutic potential.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Autoantigens; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; DNA-Binding Proteins; Drug Synergism; Fingolimod Hydrochloride; Gene Expression Regulation, Neoplastic; Histone Chaperones; HT29 Cells; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Propylene Glycols; Protein Phosphatase 2; Signal Transduction; Sphingosine; Transcription Factors | 2014 |
FTY720-induced enhancement of autophagy protects cells from FTY720 cytotoxicity in colorectal cancer.
Topics: Antineoplastic Agents; Apoptosis; Autoantigens; Autophagy; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Fingolimod Hydrochloride; G1 Phase Cell Cycle Checkpoints; Humans; Inhibitory Concentration 50; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Protein Phosphatase 2 | 2016 |
Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cell Line, Tumor; Cetuximab; Colorectal Neoplasms; Disease Models, Animal; Drug Resistance, Neoplasm; Fingolimod Hydrochloride; Gene Expression; Humans; Mice; Mice, Nude; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; Sphingosine-1-Phosphate Receptors; Treatment Outcome; Xenograft Model Antitumor Assays | 2013 |